# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-007701
Filing Date
2022-03-30
Accepted
2022-03-30 16:41:52
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | nby20220324_defa14a.htm | DEFA14A | 8217
2 |  | c01.jpg | GRAPHIC | 993344
3 |  | c02.jpg | GRAPHIC | 856726
| Complete submission text file | 0001437749-22-007701.txt |  | 2548434

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 22787097
SIC: 2834 Pharmaceutical Preparations